Funding Update
Internal + Extramural Opportunities
Extramural Opportunities
Please visit our website to find the complete and updated list of cancer-focused extramural funding opportunities or subscribe to UFHCC Opportunity to receive the weekly email.
Internal
Pilot Research Program
MOO Program Collaborative Pilot
Application: 10/4/19
Extramural (Limited)
National Institute of Health (NIH)
The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)
LOI Deadline: 9/13/2019
Extramural (Non-Limited)
National Cancer Institute
Novel Technology Tools to Facilitate Research Using Next Generation Patient-derived Cancer Models (U01 Clinical Trial Not Allowed)
Application: 9/1/19
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)
Application: 9/28/19
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)
Application: 9/28/19
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
Application: 9/28/19
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)
Application: 9/28/19
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)
Application: 9/28/19
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional)
Application: 9/28/19
Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R01 Clinical Trial Optional)
Application: 11/16/2020
Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R21 Clinical Trial Optional)
Application: 11/16/2020
National Institute of Health
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)
Application: 9/28/19
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)
Application: 9/28/19
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed)
Application: 9/28/19
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)
Application: 9/28/19
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
Application: 11/21/19
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)
Application: 11/21/19
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
Application: 11/21/19
Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors (U01 Clinical Trial Required)
Application: 1/4/20
Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional)
Application: 7/31/20
Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional)
Application: 8/4/20
Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20 Clinical Trial Optional)
Application: 10/19/20
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
Application: 5/8/21
Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)
Application: 6/18/21
Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21 Clinical Trial Not Allowed)
Application: 11/9/21
Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed)
Application: 11/9/21
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)
Application: 1/8/22
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional)
Application: 1/8/22
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional)
Application: 1/8/22
Biology of Bladder Cancer (R01 Clinical Trial Optional)
Application: 5/8/22
Biology of Bladder Cancer (R21 Clinical Trial Optional)
Application: 5/8/22
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional)
Application: 1/8/22
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21 Clinical Trial Optional)
Application: 1/8/22
Microbial-based Cancer Therapy – Bugs as Drugs (R21 Clinical Trial Not Allowed)
Application: 5/8/22
Microbial-based Cancer Therapy -Bugs as Drugs (R01 Clinical Trial Not Allowed)
Application: 5/8/22
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer (R01 Clinical Trial Optional)
Application: 12/11/21
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
Application: 11/21/19
Research Projects in Cancer Systems Biology (U01 Clinical Trial Optional)
Application: 11/16/21
Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R01 Clinical Trial Optional)
Application: 11/9/21
Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R21 Clinical Trial Optional)
Application: 11/9/21
Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21 Clinical Trial Optional)
Application: Multiple submission dates
Exploratory Grants in Cancer Epidemiology (R21 Clinical Trial Optional)
Application: 10/9/21
Postdoctoral Research Associate Training (PRAT) Program (Fi2)
Application: 10/5/21
Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed)
Application: 3/9/21
Maximizing the Scientific Value of Existing Biospecimen Collections (R21 Clinical Trial Not Allowed)
Application: 3/9/21
Tobacco Regulatory Science (R01 Clinical Trial Optional)
Application: 2/14/21
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
Application: 2/12/22
Participant Engagement and Cancer Genome Sequencing (PE-CGS): Coordinating Center (U24 Clinical Trial Not Allowed)
Application: 7/31/20
Department of Defense
Kidney Cancer Research Program: Concept Award
Application: 9/17/19
Kidney Cancer Research Program: Idea Development Award
Application: 9/17/19
Kidney Cancer Research Program: Translational Research Partnership Award
Application: 9/17/19
Research Program: Academy of Kidney Cancer Investigators – Dean Leadership Award
Application: 9/17/19
Kidney Cancer Research Program: Academy of Kidney Cancer Investigators – Early-Career Investigator Award
Application: 9/17/19
Kidney Cancer Research Program: Clinical Consortium Award
Application: 9/17/19
Melanoma Research Program: Concept Award
Application: 10/2/19
Retirement Research Foundation
Grants for Projects in Aging
Application: 5/1/20
Alex’s Lemonade Stand
RUNX1 Early Career Investigator Grant Program
Application: 12/27/19
Single-cell Pediatric Cancer Alas Request for Applications
Application: 9/30/19
Crazy 8 Initiative Award in Pediatric Cancer Research
Application: 10/1/19
Gilead Sciences
Research Scholars Program in Hematology/Oncology
Application: 9/6/19
Leukemia & Lymphoma Society
Blood Cancer Discoveries Grant Program
Application: 9/3/19
Francis Families Foundation
The Parker B. Francis Fellowship Program in Pulmonary Research
Application: 9/10/19
Brander Beacons Cancer Research
Cancer Research Funding
Application: 5/22/20
Foundation for Women’s Cancer
Foundation for Women’s Cancer/Norma Livingston Ovarian Cancer Foundation Excellence in Ovarian Cancer Research Prize
Application: 11/25/19
Perlman Family CCARE Lynch Syndrome Research Prize
Application: 11/25/19
Nina Donnelley and The Dickens Fund of the Donnelley Foundation Young Investigator Award in Honor of Laurel W. Rice, MD
Application: 11/25/19
Cancer Research Institute
CRI Irvington Postdoctoral Fellowship Program
Application: 10/1/19
Clinic & Laboratory Integration Program (CLIP)
Application: 11/5/19
Lymphoma Research Foundation
Clinical Investigator Career Development Award
Application: 9/5/19
Lymphoma Clinical Research Mentoring Program
Application: 9/5/19
Postdoctoral Fellowship
Application: 9/5/19
Elsa U. Pardee Foundation
Cancer Research Grants
Application: Multiple Submission Dates
Mike Slive Foundation
Pilot Grant Program in Prostate Cancer Research
Application: 10/1/19
American Association for Advancement of Science
Sartorius & Science Prize for Regenerative Medicine & Cell Therapy
Application: 10/1/19
American Lung Association
American Lung Association/TSF Lung Cancer Research Award
Application: 9/15/19
Lung Cancer Discovery Award
Application: 10/3/19
National Foundation for Cancer Research
Albert Szent-Gyorgyi Prize for Progress in Cancer Research
Application: 9/30/19
Pfizer
2019 Global Breast Cancer Competitive Grant Research Program
Application: 10/15/19
Melanoma Research Alliance
Special Opportunity: ASTRO-MRA Young Investigator Award in Radiation Oncology
Application: 11/4/2019
Concern Foundation
Conquer Cancer Now Award
Application: 9/5/2019